Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2888 of 5804
-
New lung cancer drug shows promise in japanese study
Disease control CompletedSecondary data collection study: safety and efficacy of VIZIMPRO under Japanese medical practice
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Brain zaps and ultrasound may help Parkinson's patients stay steady
Symptom relief OngoingThis trial aims to understand the mechanism and to test whether transcranial direct current stimulation (tDCS) combined with transcranial ultrasound (TUS) (tDCS+TUS) combined with physical therapy (PT) will induce significant therapeutic effects in postural instability in Parkins…
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New study tests if guided exercise beats simple advice for fibromyalgia fatigue
Symptom relief OngoingFibromyalgia affects 2 to 5% of adults in the general population. Patients describe a combination of symptoms centred around fatigue not induced by exercise and not relieved by rest. The diagnosis of fibromyalgia is self-perpetuating by the deconditioning, consequence of a reduc…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New program aims to keep mentally ill out of jail
Disease control CompletedThis study evaluates the Rochester Forensic Assertive Community Treatment (R-FACT) model in Minnesota. R-FACT is an enhanced version of Assertive Community Treatment designed to support individuals with serious mental illness who are involved in the criminal justice system. Part…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New immunotherapy flotetuzumab tested in kids with Tough-to-Treat leukemia
Disease control OngoingThis phase I trial studies the side effects, best dose of flotetuzumab and how well it works in treating patients with acute myeloid leukemia (AML) that has come back (recurrent) or has not responded to treatment (refractory). This study also determines the safest dose of flotetu…
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can cash rewards for clean tests boost alcohol recovery?
Disease control CompletedPhosphatidylethanol (PEth) is a direct biomarker of alcohol that can detect moderate to heavy drinking with high sensitivity and specificity over 3-week periods. Reinforcing negative PEth results alongside attendance may increase the proportion of participants who respond to CM d…
Phase: NA • Sponsor: UConn Health • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
110,000 patients join massive DNA study to unlock disease secrets
Knowledge-focused OngoingThis clinical trial collects information on how sequencing a patient's deoxyribonucleic acid (DNA) (i.e., the genetic material) could impact their health care. This study also develops and improves ways to include genomic information from DNA sequencing into the electronic health…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Ancient QiGong movement may rewire the brain to quiet chronic back pain
Symptom relief Recruiting nowThe long-term objective of this investigation is to identify how Qigong affects brain function in brain areas relevant to patients with chronic low back pain (cLBP), thereby setting a foundation from which to perform further clinical research.
Phase: NA • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Meals on prescription: study tests food as diabetes medicine
Disease control CompletedThis pragmatic randomized controlled trial will assess the efficacy of medically tailored meals and medical nutrition therapy via telehealth on clinical outcomes for patients with poorly controlled type 2 diabetes. The goal of these interventions is to improve outcomes for patien…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Laser or magnets for wrist pain? study pits new therapies against standard care
Symptom relief CompletedThis retrospective study aims to compare the clinical effectiveness of conventional physical therapy, high-intensity laser therapy (HILT), and pulsed magnetic field therapy (PMFT) in individuals with carpal tunnel syndrome (CTS). The study evaluates changes in pain, symptom sever…
Sponsor: KTO Karatay University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New pill for tough tumors enters human testing
Disease control Recruiting nowThis is an open-label phase 1 study to determine the safety and tolebility of oral ABSK021 in patients with advanced solid tumor as well as the Recommended Phase 2 dose (RP2D) of oral ABSK021. Preliminary antitumor activity will also be assessed.
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New scan could spot lymphoma without PET
Diagnosis CompletedThe study should evaluate the biological distribution of 99mTc-1-thio-D-glucose in patients with Hodgkin Lymphoma and Non Hodgkin Lymphoma. The primary objective are: 1. To assess the distribution of 99mTc-1-thio-D-glucose in normal tissues and tumors at different time interval…
Phase: PHASE1 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
Could exercise boost gut health and ease fatigue in breast cancer survivors?
Knowledge-focused OngoingThe primary goal of this project is to determine the effects of exercise on the gut microbiome in breast cancer survivors and determine how these changes may relate to psychosocial symptoms such as fatigue.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:14 UTC
-
Huge canadian study tracks rare cancer mutations to improve treatment
Knowledge-focused Recruiting nowThis study will collect data on Canadian cancer patients that have uncommon/rare changes in their tumours, such as alterations/rearrangements in the genetic material inside cells - known as deoxyribonucleic acid, or DNA, which acts as a map and gives directions to the cells on ho…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New strategy could spare patients from unnecessary blood thinners
Diagnosis CompletedThe purpose is to assess the safety of a management strategy based on colour doppler ultrasound (CDUS) and D-Dimer test results for the diagnosis exclusion of recurrent deep vein thrombosis (DVT) of the lower limbs. DVT recurrence requires using anticoagulant treatment to preven…
Phase: NA • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Liver drug maralixibat tested for Long-Term safety in rare disease patients
Disease control CompletedEvaluate the long-term safety of maralixibat (MRX) in subjects with cholestatic liver disease including, but not limited to, Alagille Syndrome (ALGS), Progressive Familial Intrahepatic Cholestasis (PFIC) and Biliary Atresia.
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThe objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Phase: PHASE2, PHASE3 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Blood test could predict cancer return after surgery
Knowledge-focused Recruiting nowCirculating tumor DNA (ctDNA) is a blood-based test that measures dying or dead cancer cells that are already circulating in the blood. In this study, the investigators will enroll patients who are planning to receive surgery to remove their head and neck cancer. The investigator…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Experimental drug KZR-616 tested for rare muscle disorders
Disease control CompletedThis was a Phase 2 randomized, double-blind, placebo-controlled, crossover, multicenter study to evaluate the safety, tolerability, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of treatment with KZR-616 in patients with active polymyositis (PM) or dermatomyositis (DM…
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Blood test may spot lung cancer without a needle biopsy
Diagnosis TerminatedThis trial collects and studies blood samples via fluid biopsy for the diagnosis of lung cancer. Studying blood samples in the laboratory may help doctors develop a blood test for lung cancer in the future and provide a better way to screen patients for lung cancer.
Sponsor: University of Southern California • Aim: Diagnosis
Last updated Jun 26, 2026 13:46 UTC